Fibromyalgia
Description
An in-depth report on the causes, diagnosis, treatment, and prevention of fibromyalgia.
Alternative Names
Fibromyositis; Fibrositis; Myofascial pain syndrome
Highlights
Risk Factors:
As many as 6 million Americans have fibromyalgia. Risk factors include being female, having had difficult experiences in childhood, having a psychological vulnerability to stress, and coming from a very stressful culture or environment.
Fibromyalgia and PTSD:
Studies have reported a greater number of severe experiences of abuse in patients with fibromyalgia, compared with the general population. This suggests that post-traumatic stress disorder (PTSD) or chronic stress may play a strong role in the development of fibromyalgia in some patients.
Drug Research News
-
Milnacipran, an antidepressant not yet approved in the U.S., is in Phase III trials for the treatment of fibromyalgia. Though results from the first Phase III trial did not show a significant benefit for this drug, the manufacturer is undergoing a second, longer, and larger trial.
-
Study results, presented in November 2006, show pregabalin cut fibromyalgia pain by at least 50% in 63% of patients, and the effect was long-lasting.
-
Pramipexole, a drug used to treat Parkinson’s disease and restless legs syndrome, may cut fibromyalgia-related pain symptoms in half, according to a study published in the journal
Arthritis and Rheumatism.
Research:
-
A 2004 report, published in the journal
Sleep,
found that sleep disorders that cause breathing problems are common in women with fibromyalgia.
-
Areas in the brain that are responsible for the sensation of pain are different in fibromyalgia patients from the same areas in healthy people, according to research published in the December 2006 issue of
Current Pain and Headache Reports
.
-
Review Date: 12/15/2006
-
Reviewed By: Harvey Simon, MD, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's
accreditation program
is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s
editorial process
. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
|
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
